ECG changes and C-protein level variations during and after treatment with atorvastatin at different dosages in the secondary prevention of stroke. - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2009年2月23日最近更新: 2014年2月10日

适应症

试验速览

暂无简介。

•Age ranging from 18 and 90 years;
•-Ischemic cerebral stroke with a neurologic syndrome related to a partial or complete infarct of posterior and/or anterior cerebral vascularization territory, following Bamford criteria. Included patients have to present one of the following clinical presentations:
•1.at least one fo the following neurological deficits (depending to just one hemisphere impairment):
•1.a.dysphasia or dyscalculia (for the impairment of the dominant hemisphere), visuo-spatial defict (i.e. neglect) for the impairment of the non-dominant hemisphere;
•1.b.motor or sensory deficit involving at least two somatic districts, including face, arm and leg in the same side.
•1.c.Homonymous hemianopsia or quadrantanopsia.
•2.isolated superior function cerebral deficit.
•3.motor or sensory deficit involving one arm or the face and the hand of the affected side.
•4. vertebro-basilar syndrome.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

发起方

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI